Imbruvica 140 mg
Imbruvica 140 mg is a medicine authorised by Swissmedic under authorisation number 67109. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 April 2019 and the authorisation is valid without a time limit. ATC code L01EL01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67109 |
|---|---|
| Name | Imbruvica 140 mg |
| Full name | Imbruvica 140 mg, Filmtabletten |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EL01 |
| First authorisation | 18 April 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Imbruvica 140 mg, Filmtabletten | A | 18 April 2019 |
| 2 | Imbruvica 280 mg, Filmtabletten | A | 18 April 2019 |
| 3 | Imbruvica 420 mg, Filmtabletten | A | 18 April 2019 |
| 4 | Imbruvica 560 mg, Filmtabletten | A | 18 April 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 28 | Tablette(n) | L01EL01 | 07.16.1. | A |
| 6 | 28 | Tablette(n) | L01EL01 | 07.16.1. | A |
| 7 | 28 | Tablette(n) | L01EL01 | 07.16.1. | A |
| 8 | 28 | Tablette(n) | L01EL01 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Imbruvica 140 mg authorised in Switzerland?
Yes. Imbruvica 140 mg is authorised by Swissmedic under authorisation number 67109, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Imbruvica 140 mg have?
Imbruvica 140 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Imbruvica 140 mg?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.